Table of contents
Volume 101, Issue 2
Published online 14 July 2009 (209-378)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Corrigendum
Review
The opposing roles of Wnt-5a in cancer FREE
S L McDonald and A Silver
Br J Cancer 101: 209-214; doi:10.1038/sj.bjc.6605174
Clinical Studies
Management and prognosis of pancreatic cancer over a 30-year period
M David, C Lepage, J-L Jouve, V Jooste, M Chauvenet, J Faivre and A-M Bouvier
Br J Cancer 101: 215-218; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605150
Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
V Gregorc, A Santoro, E Bennicelli, C J A Punt, G Citterio, J N H Timmer-Bonte, F Caligaris Cappio, A Lambiase, C Bordignon and C M L van Herpen
Br J Cancer 101: 219-224; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605162
Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
F Ohyanagi, N Yamamoto, A Horiike, H Harada, T Kozuka, H Murakami, K Gomi, T Takahashi, M Morota, T Nishimura, M Endo, Y Nakamura, A Tsuya, T Horai and M Nishio
Br J Cancer 101: 225-231; doi:10.1038/sj.bjc.6605152
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
N Tubiana-Mathieu, P Bougnoux, D Becquart, A Chan, P-F Conte, F Majois, M Espie, M Morand, N Vaissiere and G Villanova
Br J Cancer 101: 232-237; advance online publication, July 7, 2009; doi:10.1038/sj.bjc.6605156
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
J S Thompson Coon, Z Liu, M Hoyle, G Rogers, C Green, T Moxham, K Welch and K Stein
Br J Cancer 101: 238-243; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605167
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
I Vandenput, B Van Calster, A Capoen, K Leunen, P Berteloot, P Neven, Ph Moerman, I Vergote and F Amant
Br J Cancer 101: 244-249; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605157
Factors affecting attitudes toward colorectal cancer screening in the primary care population
T Taskila, S Wilson, S Damery, A Roalfe, V Redman, T Ismail and R Hobbs
Br J Cancer 101: 250-255; advance online publication, June 23, 2009; doi:10.1038/sj.bjc.6605130
Translational Therapeutics
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines
T Zaremba, P Ketzer, M Cole, S Coulthard, E R Plummer and N J Curtin
Br J Cancer 101: 256-262; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605166
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis FREE
T Koreckij, H Nguyen, L G Brown, E Y Yu, R L Vessella and E Corey
Br J Cancer 101: 263-268; doi:10.1038/sj.bjc.6605178
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition
X Ding, A B Mohd, Z Huang, T Baba, M Q Bernardini, H K Lyerly, A Berchuck, S K Murphy, A B Buermeyer and G R Devi
Br J Cancer 101: 269-277; doi:10.1038/sj.bjc.6605180
Molecular Diagnostics
Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
A J Ryan, S Napoletano, P A Fitzpatrick, C A Currid, N C O'Sullivan and J H Harmey
Br J Cancer 101: 278-286; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605141
Annexin II represents metastatic potential in clear-cell renal cell carcinoma
Y Ohno, M Izumi, T Kawamura, T Nishimura, K Mukai and M Tachibana
Br J Cancer 101: 287-294; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605128
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer
Y Mohri, T Mohri, W Wei, Y-J Qi, A Martin, C Miki, M Kusunoki, D G Ward and P J Johnson
Br J Cancer 101: 295-302; advance online publication, June 23, 2009; doi:10.1038/sj.bjc.6605138
Isolation of tumour stem-like cells from benign tumours
Q Xu, X Yuan, P Tunici, G Liu, X Fan, M Xu, J Hu, J Y Hwang, D L Farkas, K L Black and J S Yu
Br J Cancer 101: 303-311; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605142
Episodic Src activation in uveal melanoma revealed by kinase activity profiling
W Maat, M el Filali, A Dirks- Mulder, G P M Luyten, N A Gruis, L Desjardins, P Boender, M J Jager and P A van der Velden
Br J Cancer 101: 312-319; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605172
Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells
S C Kirkland
Br J Cancer 101: 320-326; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605143
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
X N Meng, Y Jin, Y Yu, J Bai, G Y Liu, J Zhu, Y Z Zhao, Z Wang, F Chen, K-Y Lee and S B Fu
Br J Cancer 101: 327-334; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605154
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
E Cocco, S Bellone, K El-Sahwi, M Cargnelutti, F Casagrande, N Buza, F A Tavassoli, E R Siegel, I Visintin, E Ratner, D-A Silasi, M Azodi, P E Schwartz, T J Rutherford, S Pecorelli and A D Santin
Br J Cancer 101: 335-341; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605129
Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition
W Li, Y Xie, R W-Y Sun, Q Liu, J Young, W-Y Yu, C-M Che, P K Tam and Y Ren
Br J Cancer 101: 342-349; advance online publication, June 23, 2009; doi:10.1038/sj.bjc.6605147
Genetics and Genomics
The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models
N Faur, L Araud, A Laroche-Clary, J Kanno, J Toutain, T Yamori, J Robert and V Le Morvan
Br J Cancer 101: 350-356; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605096
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array
D M Kweekel, N F Antonini, J W R Nortier, C J A Punt, H Gelderblom and H-J Guchelaar
Br J Cancer 101: 357-362; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605134
Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia
N Ban and M Kai
Br J Cancer 101: 363-371; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605135
Letters to the Editor
Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
P N Span, I D Nagtegaal and J Bussink
Br J Cancer 101: 372; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605090
Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
E Korkeila, K Talvinen, P M Jaakkola, H Minn, K Syrjänen, J Sundström and S Pyrhönen
Br J Cancer 101: 373; advance online publication, June 30, 2009; doi:10.1038/sj.bjc.6605151
Do we need biopsies of metastases for colorectal cancer patients?
I Floriani, D Santini, V Torri, C Cremolini, A Falcone and F Loupakis
Br J Cancer 101: 374-375; advance online publication, July 7, 2009; doi:10.1038/sj.bjc.6605131
Reply: Do we need biopsies of metastases for colorectal cancer patients?
M Frattini, F Molinari, P Saletti and L Mazzucchelli
Br J Cancer 101: 376; advance online publication, July 7, 2009; doi:10.1038/sj.bjc.6605170
Corrigendum
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers FREE
M K Maw, J Fujimoto and T Tamaya
Br J Cancer 101: 377-378; doi:10.1038/sj.bjc.6605205
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
